Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

PROCEPT BioRobotics Corporation - Common Stock (NQ:PRCT)

21.21 +0.18 (+0.86%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 6, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,407,683
Open	20.70
Bid (Size)	20.98 (200)
Ask (Size)	23.90 (100)
Prev. Close	21.03
Today's Range	20.21 - 21.88
52wk Range	19.35 - 62.17
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval

May 28, 2026

From PROCEPT BioRobotics

Via GlobeNewswire

What to Know About This Fund's $10 Million Nektar Bet Ahead of a Key Phase 3 Launch ↗

May 23, 2026

Biotech firm Nektar Therapeutics advances a pipeline of immunology and oncology candidates through research-driven collaborations.

Via The Motley Fool

Performance

YTD	-31.0%	-31.0%
1 Month	-23.8%	-23.8%
3 Month	-10.8%	-10.8%
6 Month	-36.0%	-36.0%
1 Year	-62.8%	-62.8%

More News

This Healthcare Investor Added $43 Million to a Genomics Leader Growing Volume 34% ↗

May 23, 2026

Via The Motley Fool

PROCEPT BIOROBOTICS CORP (NASDAQ:PRCT) Q1 Earnings Beat Drives 13% Surge Despite Net Loss ↗

April 29, 2026

Via Chartmill

5 Robotics Stocks to Watch as Physical AI Builds Momentum ↗

May 18, 2026

Via MarketBeat

AUA Guidelines Strengthen Recommendation for Aquablation® Therapy

May 14, 2026

From PROCEPT BioRobotics

Via GlobeNewswire

PROCEPT BioRobotics® to Attend Three Upcoming Investor Conferences in May & June

April 30, 2026

From PROCEPT BioRobotics

Via GlobeNewswire

Procept (PRCT) Q1 2026 Earnings Transcript ↗

April 30, 2026

Via The Motley Fool

What's going on in today's after hours session ↗

April 29, 2026

Via Chartmill

PROCEPT BioRobotics Reports First Quarter 2026 Financial Results

April 29, 2026

From PROCEPT BioRobotics

Via GlobeNewswire

Chicago Capital Doubles Down on PROCEPT BioRobotics, Adds $27 Million in Stock ↗

April 24, 2026

Via The Motley Fool

Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

April 22, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

April 22, 2026

From Law Offices of Howard G. Smith

Via Business Wire

Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

April 22, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

PROCEPT BioRobotics (PRCT) Earnings Transcript ↗

April 14, 2026

Via The Motley Fool

PROCEPT BioRobotics® to Report First Quarter 2026 Financial Results on April 29, 2026

April 09, 2026

From PROCEPT BioRobotics

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PROCEPT BioRobotics Corporation - PRCT

March 24, 2026

From Pomerantz LLP

Via GlobeNewswire

EAU Guidelines Upgrade Aquablation® Therapy to Strong Surgical Recommendation for BPH

March 23, 2026

From PROCEPT BioRobotics

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PROCEPT BioRobotics Corporation - PRCT

March 17, 2026

From Pomerantz LLP

Via GlobeNewswire

PROCEPT BioRobotics® Announces International Launch of the HYDROS® Robotic System, Expanding Global Access to AI-Enabled Aquablation® Therapy

March 12, 2026

From PROCEPT BioRobotics

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PROCEPT BioRobotics Corporation - PRCT

March 10, 2026

From Pomerantz LLP

Via GlobeNewswire

Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

March 10, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

March 10, 2026

From Law Offices of Howard G. Smith

Via Business Wire

Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

March 09, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

PRCT Investors Have Opportunity to Join PROCEPT BioRobotics Corporation Fraud Investigation with the Schall Law Firm

March 08, 2026

From The Schall Law Firm

Via Business Wire

Frequently Asked Questions

Is PROCEPT BioRobotics Corporation - Common Stock publicly traded?

Yes, PROCEPT BioRobotics Corporation - Common Stock is publicly traded.

What exchange does PROCEPT BioRobotics Corporation - Common Stock trade on?

PROCEPT BioRobotics Corporation - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for PROCEPT BioRobotics Corporation - Common Stock?

The ticker symbol for PROCEPT BioRobotics Corporation - Common Stock is PRCT on the Nasdaq Stock Market

What is the current price of PROCEPT BioRobotics Corporation - Common Stock?

The current price of PROCEPT BioRobotics Corporation - Common Stock is 21.21

When was PROCEPT BioRobotics Corporation - Common Stock last traded?

The last trade of PROCEPT BioRobotics Corporation - Common Stock was at 07/06/26 04:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.